Biogen Inc risk profile
56 Elevated one input has moved against it
Measured 21 October 2026 from BIIB's filed statements. Recomputed nightly.
56 (Elevated), driven by Concentration at 69, over 5 weighted categories on the MANUFACTURER profile.
What is measured
| Mechanism | Reading | Band | Direction | Driver |
|---|---|---|---|---|
| Market expectation | 22 | Normal | Stable | One-year price volatility — 33.5% |
| Operating pressure | Reads cost_of_revenue, operating_expense, operating_income and revenue. No reading is stored for this company. | |||
| Cash conversion | 16 | Contained | Stable | Capital spending against operating cash — 0.07x |
| Leverage and coverage | 22 | Normal | Easing | Interest cover — 9.73x |
| Competitive position | 64 | Stretched | Stable | Operating-margin gap against peers — -4.2 percentage points |
| Concentration | 69 | Stretched | Stable | Supplier concentration — 10,000 HHI |
These are descriptive readings of disclosed mechanisms, not investment advice, and not a prediction. A band says where a measured input sits, never what to do about it or what happens next.